High-density lipoproteins at the interface between central nervous system and plasma lipoprotein metabolism-Reference-Cited by-同舟云学术

High-density lipoproteins at the interface between central nervous system and plasma lipoprotein metabolism

Published:2015-02-01 Issue:1 Volume:10 Page:69-81
ISSN:1758-4299
Container-title:Clinical Lipidology
language:en
Short-container-title:Clinical Lipidology

Author:

Robert Jérôme¹,Cheng Wai Hang¹,Hayat Arooj¹,Ward-Able Taylor¹,Wellington Cheryl L¹

Affiliation:

1. Department of Pathology & Laboratory Medicine, Djavad Mowafaghian Centre for Brain Health, University of British Columbia, 2329 West Mall, Vancouver, BC, V6T 1Z4, Canada

Publisher

Informa UK Limited

Subject

Cardiology and Cardiovascular Medicine,Endocrinology, Diabetes and Metabolism

Link

https://www.tandfonline.com/doi/pdf/10.2217/clp.14.64

Reference156 articles.

1. Redzic Z. Molecular biology of the blood–brain and the blood–cerebrospinal fluid barriers: similarities and differences. Fluids Barriers CNS 8(1), 3 (2011).

2. Hegele RA. Plasma lipoproteins: genetic influences and clinical implications. Nat. Rev. Genet. 10(2), 109–121 (2009).

3. Linton MF, Gish R, Hubl ST et al. Phenotypes of apolipoprotein B and apolipoprotein E after liver transplantation. J. Clin. Invest. 88(1), 270–281 (1991).

4. Riwanto M, Landmesser U. High-density lipoproteins and endothelial functions: mechanistic insights and alterations in cardiovascular disease. J. Lipid Res. 54(12), 3227–3243 (2013). • describes the modification of HDL function in cardiovascular disease.

5. Toledo JB, Arnold SE, Raible K et al. Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer’s Coordinating Centre. Brain 136(Pt 9), 2697–2706 (2013).

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathophysiological Aspects and Therapeutic Armamentarium of Alzheimer’s Disease: Recent Trends and Future Development;Cellular and Molecular Neurobiology;2023-09-19

2. Interactions of Lipids, Lipoproteins, and Apolipoproteins with the Blood-Brain Barrier;Pharmaceutical Research;2021-09